Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21 (Q79791286)
Jump to navigation
Jump to search
scientific article published on 01 May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21 |
scientific article published on 01 May 2006 |
Statements
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21 (English)
Gary M Clark
Denni M Zborowski
Pedro Santabarbara
Keyue Ding
Marlo Whitehead
Lesley Seymour
Frances A Shepherd
National Cancer Institute of Canada Clinical Trials Group